BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| Motesanib | Motesanib is a multikinase inhibitor that selectively targets VEGF receptors, platelet-derived growth factor receptors (PDGFRs), and Kit receptors. It also potently inhibits angiogenesis and induces regression in tumor xenografts. Uses: Protein kinase inhibitors. Group: Pharmaceutical. CAS No. 453562-69-1. Pack Sizes: 100 mg. Product ID: B0084-069090. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Motesanib Diphosphate | Motesanib Diphosphate is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of 2 nM/3 nM/6 nM, respectively; similar activity against Kit, ~10-fold more selective for VEGFR than PDGFR and Ret. Uses: Protein kinase inhibitors. Group: Pharmaceutical. CAS No. 857876-30-3. Pack Sizes: 50 mg. Product ID: B0084-153042. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Motolimod | Motolimod is a small-molecule agonist of TLR8, with potential immunostimulating and antineoplastic activities. Group: Pharmaceutical. CAS No. 926927-61-9. Pack Sizes: 100 mg. Product ID: B0084-462238. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MOTS-C | MOTS-C is a peptide hormone encoded in the mitochondrial genome. It regulates metabolic homeostasis and enhances physical performance. Group: Pharmaceutical. CAS No. 1627580-64-6. Pack Sizes: 100 mg. Product ID: BAT-006155. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxidectin | Moxidectin is an anthelmintic drug which kills parasitic worms (helminths), and is used for the prevention and control of heartworm and intestinal worms. Moxidectin can be used to prevent heartworm infection in dogs. Moxidectin is a semisynthetic derivative of nemadectin which is produced by fermentation by Streptomyces cyano-griseus. Uses: Insecticides. Group: Pharmaceutical. CAS No. 113507-06-5. Pack Sizes: 10 g. Product ID: BBF-03800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxidectin Impurities | Moxidectin Impurities, crucial for quality control in pharmaceuticals, are examined to ensure the purity and safety of moxidectin, an anthelmintic drug. This drug is employed in the treatment of parasitic infections, including onchocerciasis and lymphatic filariasis, underscoring the significance of identifying and evaluating these impurities in biomedical research. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin-[d3] | Moxifloxacin-[d3] is a labelled form of Moxifloxacin. Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specfically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. Group: Pharmaceutical. CAS No. 1092356-42-7. Pack Sizes: 10 mg. Product ID: BLP-013398. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin EP Impurity B | An impurity of Moxifloxacin, a fourth-generation antibacterial drug. Group: Pharmaceutical. CAS No. 1029364-73-5. Pack Sizes: 5 mg. Product ID: B2694-310725. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin EP Impurity D | An impurity of Moxifloxacin, a fourth-generation antibacterial drug. Group: Pharmaceutical. CAS No. 1029364-77-9. Pack Sizes: 25 mg. Product ID: B2694-261498. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Hydrochloride | Moxifloxacin exerts its effects by trapping a DNA drug enzyme complex and specifically inhibiting ATP-dependent enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. It is a fluoroquinolone antibiotic with broad-spectrum bactericidal activity against gram-positive and gram-negative strains. Group: Pharmaceutical. CAS No. 186826-86-8. Pack Sizes: 100 g. Product ID: BBF-04614. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Impurities | Moxifloxacin Impurities hold paramount significance within the biomedical realm, fundamentally underpinning quality assurance for moxifloxacin, an antibiotic of profound efficacy against bacterial infections, notably respiratory ailments. These impurities are essential to ascertain the drug's safety, efficacy, and durability, thereby ensuring adherence to regulatory mandates in pharmacological contexts. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin impurity 001 | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Group: Pharmaceutical. Pack Sizes: 2 mg. Product ID: B2694-338791. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Impurity 18 | An impurity of Moxifloxacin, which is fourth generation antibacterial agent. Group: Pharmaceutical. CAS No. 172426-88-9. Pack Sizes: 100 mg. Product ID: B0037-477850. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Impurity E | An impurity of Moxifloxacin, which is a fourth generation antibacterial agent. Group: Pharmaceutical. CAS No. 1292904-74-5. Pack Sizes: 25 mg. Product ID: B2694-477847. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Related Compound A (HCl salt form) | An impurity of Moxifloxacin. Moxifloxacin is an antibiotic used to treat bacterial infenctions such as community acquired pneumonia, complicated skin infections and complicated intra-abdominal infections. Group: Pharmaceutical. CAS No. 151282-23-4. Pack Sizes: 25 mg. Product ID: B0037-007221. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxifloxacin Related Compound G | An impurity of Moxifloxacin. Moxifloxacin is an antibiotic used to treat bacterial infenctions such as community acquired pneumonia, complicated skin infections and complicated intra-abdominal infections. Group: Pharmaceutical. CAS No. 1394029-14-1. Pack Sizes: 5 mg. Product ID: B0037-007222. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moxonidine Impurities | Moxonidine Impurities, integral to biomedical endeavors, serve a crucial role in evaluating the purity and stability of moxonidine as an antihypertensive agent. Their essential participation in quality control and regulatory compliance guarantees moxonidines therapeutic efficacy and safety, vital for the management of hypertension and related cardiovascular conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mozavaptan | Mozavaptan (OPC-31260) inhibits AVP binding to V1 and V2 receptors in a competitive manner. Uses: Antidiuretic hormone receptor antagonists. Group: Pharmaceutical. CAS No. 137975-06-5. Pack Sizes: 500 mg. Product ID: B2693-058123. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| mPEG2000C-DMG | mPEG2000C-DMG, a polyethylene glycol derivative renowned for its pivotal role in surface modification for drug delivery and as a crucial linker in antibody-drug conjugates. Its widespread application in the realm of nanoparticle-based therapies, especially in the combat against cancer and various maladies, underscores its significance in the pharmaceutical landscape. Group: Pharmaceutical. CAS No. 1019000-64-6. Pack Sizes: 500 mg. Product ID: B2699-358145. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MPEG2000-DSPE Sodium Salt | MPEG2000-DSPE Sodium Salt can be used for the preparation of stabilized nucleic acid-lipid particllipid particles (SNALPs), which represent some of the earliest and best functional siRNA-ABC nanoparticles described. Group: Pharmaceutical. CAS No. 247925-28-6. Pack Sizes: 1 g. Product ID: B1370-291962. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| mPEG8-thiol | m-PEG8-thiol is a polyethylene glycol (PEG)-based PROTAC linker. m-PEG8-thiol can be used in the synthesis of a series of PROTACs. Group: Pharmaceutical. CAS No. 651042-83-0. Pack Sizes: 1 g. Product ID: B1370-264132. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MPO-IN-28 | MPO-IN-28 is a myeloperoxidase (MPO) inhibitor with IC50 of 44 nM. Group: Pharmaceutical. CAS No. 37836-90-1. Pack Sizes: 50 mg. Product ID: B1370-381586. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MRE-269 | MRE-269 is an orally available and long-acting prostacyclin receptor agonist prodrug used for the treatment of pulmonary arterial hypertension. Uses: Prostacyclin receptor agonist. Group: Pharmaceutical. CAS No. 475085-57-5. Pack Sizes: 10 mg. Product ID: B0084-475745. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MRT67307 | This active molecular is a potent ULK1/2 inhibitor and the IC50 value is 2.9 nM and 1.1 nM. MRT68921 is also a SIK inhibitor. Group: Pharmaceutical. CAS No. 1190378-57-4. Pack Sizes: 10 mg. Product ID: B2693-457418. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MRTX1133 | MRTX1133 is a potent, selective and noncovalent inhibitor of KRASG12D, a promising target for the treatment of solid tumors. Group: Pharmaceutical. CAS No. 2621928-55-8. Pack Sizes: 50 mg. Product ID: B1370-381575. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MRTX-1719 | MRTX1719 is a potent and selective inhibitor of the PRMT5/MTA complex. Group: Pharmaceutical. CAS No. 2630904-45-7. Pack Sizes: 50 mg. Product ID: B1370-427889. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MRTX849 | MRTX849 is a potent and mutation-selective covalent inhibitor of KRAS G12C. It maximizes inhibition by irreversibly locking the KRAS molecule in its inactive state, thereby preventing tumor cell growth which results in tumor cell death. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 2326521-71-3. Pack Sizes: 50 mg. Product ID: B2693-342068. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MS023 | MS023 is a Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases. MS023 displayed high potency for type I PRMTs including PRMT1, -3, -4, -6, and -8 but was completely inactive against type II and type III PRMTs, protein lysine methyltransferases and DNA methyltransferases. Group: Pharmaceutical. CAS No. 1831110-54-3. Pack Sizes: 300 mg. Product ID: B0084-470903. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MS023 dihydrochloride | MS023 dihydrochloride is a potent, selective and cell-active human type I protein arginine methyltransferases (PRMTs) inhibitor, with IC50s of 30, 119, 83, 4 and 5 nM for PRMT1, PRMT3, PRMT4, PRMT6 and PRMT8, respectively. Group: Pharmaceutical. CAS No. 1992047-64-9. Pack Sizes: 100 mg. Product ID: B1370-382055. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MS436 | MS436 is a BRD4 bromodomain inhibitor, which exhibits 10-fold selectivity for BRD4(1) over BRD4(2). Group: Pharmaceutical. CAS No. 1395084-25-9. Pack Sizes: 50 mg. Product ID: B2693-463410. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MSC2530818 | MSC2530818 is a specific and orally available CDK8 inhibitor with an IC50 of 2.6 nM for CDK8. Group: Pharmaceutical. CAS No. 1883423-59-3. Pack Sizes: 10 mg. Product ID: B0084-007722. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MSDC-0160 | MSDC-0160 reduces resistance in the insulin/IGF-1 signaling pathway and restores IGF-1-induced Akt and GSK-3 phosphorylation. Group: Pharmaceutical. CAS No. 146062-49-9. Pack Sizes: 25 mg. Product ID: B0084-311834. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MSDC-0602 | MSDC-0602 is an insulin sensitizer that has the potential to treat diabetes and other inflammatory diseases. It exhibits low affinity for binding and activation of PPAR&gamma. Group: Pharmaceutical. CAS No. 1133819-87-0. Pack Sizes: 50 mg. Product ID: B0084-284775. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MTBD | MTBD (CAS# 84030-20-6 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 84030-20-6. Pack Sizes: 5 g. Product ID: B0001-380766. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MTDIA | MTDIA is a human 5'-methylthioadenosine phosphorylase (MTAP) inhibitor, which is solely responsible for 5'-methylthioadenosine (MTA) metabolism to permit S-adenosylmethionine salvage. It is used as an anticancer candidate. Group: Pharmaceutical. CAS No. 653592-04-2. Pack Sizes: 100 mg. Product ID: B2693-476086. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MTDIA hydrochloride | MTDIA is a methylthioadenosine phosphorylase (MTAP) inhibitor. MTAP is responsible for 5'-methylthioadenosine (MTA) metabolism to permit S-adenosylmethionine salvage. Transition-state (TS) analogues of MTAP are in development as anticancer drug candidates and MTDIA is one of these TS analogues. Uses: Anticancer drug candidate. Group: Pharmaceutical. CAS No. 1399840-35-7. Pack Sizes: 50 mg. Product ID: B0084-475405. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| m-Terphenyl | m-Terphenyl (CAS# 92-06-8) is a useful research chemical. Group: Pharmaceutical. CAS No. 92-06-8. Pack Sizes: 25 g. Product ID: B1370-331966. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MTIC | MTIC is a metabolite Temozolomide, which is an alkylating drug. Group: Pharmaceutical. CAS No. 3413-72-7. Pack Sizes: 20 mg. Product ID: B1704-017759. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MTS Reagent | MTS Reagent. Group: Pharmaceutical. CAS No. 138169-43-4. Pack Sizes: 250 mg. Product ID: B2699-049332. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mubritinib | Mubritinib, also known as TAK-165, is a protein kinase inhibitor which was under development by Takeda for the treatment of cancer. It completed phase I clinical trials (may be discontinued since 2008). Mubritinib(TAK 165) is a potent EGFR, HER2 and p34cdc2 inhibitor with IC50 of 6 nM and 0.2 μM, respectively. Mubritinib(TAK 165) also inhibits p33cdk2 and p33cdk5. Mubritinib(TAK 165) displays > 4000-fold selectivity over EGFR, FGFR, PDGFR, JAK1 and Src. Mubritinib(TAK 165) exhibits potent antiproliferative effects in ErbB2-overexpressing cancer cell lines (IC50 = 5 nM in BT474 breast cancer cells) and significantly inhibits bladder, breast and prostate cancer xenograft growth in vivo. Group: Pharmaceutical. CAS No. 366017-09-6. Pack Sizes: 50 mg. Product ID: B0084-067201. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| mu-conotoxin | mu-conotoxin. Group: Pharmaceutical. CAS No. 936616-33-0. Pack Sizes: 5 mg. Product ID: BAT-006222. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mucothiol | Mucothiol. Group: Pharmaceutical. CAS No. 19547-88-7. Pack Sizes: 100 mg. Product ID: B2699-195565. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mulberrin | Mulberrin isolated from the root bark of Morus alba L. It may as HIV-1 reverse transcriptase inhibitor. Uses: Anti-inflammatory agents. Group: Pharmaceutical. CAS No. 62949-79-5. Pack Sizes: 5 mg. Product ID: NP1990. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mulberrofuran G | Mulberrofuran G isolated from the root bark of Morus alba L. Group: Pharmaceutical. CAS No. 87085-00-5. Pack Sizes: 5 mg. Product ID: NP4658. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mulberrofuran Q | Mulberrofuran Q is found in the Morus alba. Group: Pharmaceutical. CAS No. 101383-35-1. Pack Sizes: 5 mg. Product ID: B0005-053485. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mulberroside A | Mulberroside A is a natural compound extracted from the root bark of white mulberry. Mulberroside A treatment could down-regulate P-gp expression and function accompanied by the activation of PKC and NF-κB, and this should be taken into consideration in potential herb-drug interactions when Mulberroside A or M. alba are co-administered with other drugs transported by P-gp. Group: Pharmaceutical. CAS No. 102841-42-9. Pack Sizes: 100 mg. Product ID: NP5273. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mupirocin | Mupirocin is an isoleucyl t-RNA synthetase inhibitor, used in the treatment of bacterial skin infections. Group: Pharmaceutical. CAS No. 12650-69-0. Pack Sizes: 200 mg. Product ID: BBF-03814. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mupirocin Impurities | Mupirocin Impurities, integral to pharmaceutical analytics, unravel the crucial safety and efficacy metrics of mupirocin antibiotics. Through meticulous examination, these compounds uphold therapeutic integrity, primarily addressing dermal infections such as impetigo, and combat pathogens like Staphylococcus aureus and Streptococcus pyogenes, thereby enhancing the reliability of antibiotic interventions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Muramine | Muramine is a natural dibenzazecine alkaloid found in Corydalis pallida, Papaver nudicaule, and other organisms. Group: Pharmaceutical. CAS No. 2292-20-8. Pack Sizes: 1 mg. Product ID: NP0762. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Murrangatin | Murrangatin isolated from the herbs of Murraya exotica L. Murrangatin exhibits cytotoxicity against cholangiocarcinoma cell line. And it significantly inhibits EBV-EA activation, and preserves the high viability of Raji cells. Uses: Anti-tumor-promoting; cytotoxicity. Group: Pharmaceutical. CAS No. 37126-91-3. Pack Sizes: 5 mg. Product ID: NP1048. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Murrayanine | Murrayanine is a carbazole derivative isolated from Murraya koenigii Spreng. Group: Pharmaceutical. CAS No. 723-97-7. Pack Sizes: 1 mg. Product ID: NP0660. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mussaenoside | Mussaenoside is a natural iridoid found in the herbs of Melampyrum roseum Maxim, it can inhibit the release of pro-inflammatory cytokines induced by LPS, the production of nitric oxide (NO) and prostaglandin E2, and the expression of inducible NO synthase and cyclooxygenase-2 induced by lipopolysaccharide (LPS) in the RAW264.7 murine macrophage cell line. Mussaenoside also exhibits the activity of anti-inflammatory. Uses: Anti-inflammatory. Group: Pharmaceutical. CAS No. 64421-27-8. Pack Sizes: 1 mg. Product ID: NP3859. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mutant EGFR inhibitor | Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1. It inhibits EGFRL858R, EGFRExon 19 deletionand EGFRT790M. Group: Pharmaceutical. CAS No. 1421373-62-7. Pack Sizes: 5 mg. Product ID: B0084-463231. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mutilin Impurities | Mutilin Impurities, prevalent in the pharmaceutical industry, are pivotal for assessing the purity and efficacy of mutilin-derived antibiotic drugs. These impurities aid in research related to bacterial resistance and the optimization of antimicrobials, crucial for treating infections like respiratory diseases and bacterial skin conditions effectively. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MV1 | MV1 is an IAP antagonist. IAP are a family of functionally and structurally related proteins that serve as endogenous inhibitors of programmed cell death (apoptosis). Group: Pharmaceutical. CAS No. 1001600-54-9. Pack Sizes: 5 mg. Product ID: BAT-006237. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MYBMIM | MYBMIM is a novel peptidomimetic inhibitor. It can inhibit MYB and CREB-binding protein (CBP) in acute myeloid leukemia (AML) cells. Uses: The potential treatment of acute myeloid leukemia (aml). Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-007113. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MYCMI-6 | MYCMI-6 is a selective, high affinity inhibitor of MYC-MAX interaction. MYCMI-6 inhibits tumor cell growth in a MYC-dependent manner with IC50 concentrations as low as 0.5?μM, while sparing normal cells. Group: Pharmaceutical. CAS No. 681282-09-7. Pack Sizes: 50 mg. Product ID: B2693-383250. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mycophenolate Impurities | Mycophenolate Impurities are critical in assessing the purity and stability of mycophenolate-based immunosuppressive drugs, commonly used to prevent organ transplant rejection. These impurities help ensure therapeutic efficacy and safety by identifying and controlling potential degradation products throughout drug development and quality control processes. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mycophenolate Mofetil EP Impurity D | Mycophenolate Mofetil EP Impurity D is a degradation product of Mycophenolate Mofetil, an inhibitor of inosine monophosphate dehydrogenase (IMPDH). Group: Pharmaceutical. CAS No. 1322681-37-7. Pack Sizes: 10 mg. Product ID: B2694-477892. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mycophenolate Mofetil Impurities | Mycophenolate Mofetil Impurities are integral to pharmaceutical quality control, focusing on mycophenolate mofetil, a pivotal drug in thwarting organ rejection. These impurities serve a critical role in evaluating the medication's safety and efficacy, ensuring its therapeutic prowess in both transplant care and autoimmune disorder management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mycro 3 | Mycro 3 is potent and selective inhibitor of Myc-Max dimerization. Group: Pharmaceutical. CAS No. 944547-46-0. Pack Sizes: 10 mg. Product ID: B0084-007688. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MYK-461 | MYK-461 is a myosin inhibitor that selectively decreases the ATPase activity of cardiac myosin heavy chain, thus it is potentially for the treatment of hypertrophic cardiomyopathy (HCM). Uses: Potential treatment of hypertrophic cardiomyopathy (hcm). Group: Pharmaceutical. CAS No. 1642288-47-8. Pack Sizes: 100 mg. Product ID: B2693-055153. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myrcludex B | Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide. Group: Pharmaceutical. CAS No. 2012558-47-1. Pack Sizes: 5 mg. Product ID: BAT-010104. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myricetin | Myricetin is a flavonoid found in many grapes, berries, fruits, vegetables, herbs, as well as other plants, which has antioxidant and anti tumor properties. Studies shows that high myricetin consumption reduces the risk of prostate cancer and pancreatic cancer. Myricetin has the effect of whitening skin, it is a good functional cosmetics material. Uses: Anti-hiv; anti-tumor; anti-amyloidogenic activity. Group: Pharmaceutical. CAS No. 529-44-2. Pack Sizes: 100 g. Product ID: NP1894. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myricetin 3-O-galactoside | Myricetin-3-o-galactoside is a natural flavonoid found in the root bark of Myrica cerifera L. Myricetin-3-o-galactoside exhibits antinociceptive and anti-inflammatory activities, which are related to peripheral inhibition of nitric oxide synthesis, mainly. Uses: Antinociceptive,anti-inflammatory. Group: Pharmaceutical. CAS No. 15648-86-9. Pack Sizes: 5 mg. Product ID: NP1967. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myricetin Impurities | Myricetin Impurities are critical in the biomedical sector as reference standards for quality control in drug development. They aid in analyzing the therapeutic efficacy of myricetin-derived compounds used primarily in treating inflammatory diseases and cancer. These impurities ensure the accuracy and reliability of pharmacological studies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myristoyl Hexapeptide-16 | Myristoyl Hexapeptide-16 is a synthetic peptide used for skin care and eyelash growth. Group: Pharmaceutical. CAS No. 959610-54-9. Pack Sizes: 1 g. Product ID: BAT-010792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myristoyl Hexapeptide-23 | Myristoyl Hexapeptide-23 is an anti-acne ingredient used in cosmetics. Group: Pharmaceutical. Pack Sizes: 5 mg. Product ID: BAT-006227. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myristoyl hexapeptide-5 (hydrochloride/acetate) | Myristoyl hexapeptide-5 is a synthetic peptide used in skincare products. It can suppresses acne-causing bacteria. Group: Pharmaceutical. Pack Sizes: 1 g. Product ID: BAT-016124. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Myristoyl Pentapeptide-17 | Myristoyl Pentapeptide-17 is a synthetic peptide used for skin care and eyelash growth. It activates the keratin gene, which causes eyelashes to grow and thicken. Group: Pharmaceutical. CAS No. 959610-30-1. Pack Sizes: 100 mg. Product ID: BAT-010785. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.